PATZ1 and diffuse large B-cell lymphoma: The median OS for 449 patients with high PATZ1 expression was 83 months, in contrast to 45 months for 21 patients with low PATZ1. The median PFS for patients with high PATZ1 DLBCL was > 96 months versus 11 months for patients with low PATZ1 DLBCL.